Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T LeJemtel

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
American Heart Journal|August 1, 1988
Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesB F Uretsky, J A Shaver, C S Liang, et al.
The American Journal of Cardiology|November 1, 1982
Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectorisW H Frishman, N Klein, J Strom, et al.
Journal of the American College of Cardiology|October 1, 1993
Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials InvestigatorsW S Colucci, E H Sonnenblick, K F Adams, et al.
American Heart Journal|February 26, 2000
Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunctionJ E Udelson, C A DeAbate, M Berk, et al.
Journal of the American College of Cardiology|September 14, 2000
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?S C Wong, T Sanborn, L A Sleeper, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
American Heart Journal|August 1, 1988
Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesB F Uretsky, J A Shaver, C S Liang, et al.
The American Journal of Cardiology|November 1, 1982
Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectorisW H Frishman, N Klein, J Strom, et al.
Journal of the American College of Cardiology|October 1, 1993
Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials InvestigatorsW S Colucci, E H Sonnenblick, K F Adams, et al.
American Heart Journal|February 26, 2000
Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunctionJ E Udelson, C A DeAbate, M Berk, et al.
Journal of the American College of Cardiology|September 14, 2000
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?S C Wong, T Sanborn, L A Sleeper, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Pageof 3